Moderna (MRNA) Management Meeting Hints Company is Likely to Guide Up - Jefferies
Tweet Send to a Friend
Jefferies analyst Michael Yee reiterated a Hold rating and $150.00 price target on Moderna (NASDAQ: MRNA) after meeting with management ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
